Financials
- Market Capitalization 455.93 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.65
Rapporto prezzo/fatturato
1 541.15
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2906 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.74 USD | -3.87% | -6.95% | -6.45% | +9.43% | 463.12 M USD | ||
| 2914 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.65 USD | -0.38% | -0.38% | -5.69% | +3.92% | 458.83 M USD | ||
| 2929 | YDES YD Bio Limited - Ordinary Shares | 6.33 USD | -5.94% | -8.79% | +57.86% | -65.60% | 448.10 M USD | ||
| 2939 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 8.20 USD | -1.56% | -3.53% | +26.35% | +16.48% | 442.19 M USD |